The popularity of Sildenafil initially fueled a period of growth for pharma, however recent changes present a complicated outlook for those considering a stake. Generic alternatives are eating into profits, and ongoing https://harmonyyihx575881.losblogos.com/39936923/sildenafil-and-big-pharma-a-volatile-bet